|
Hi, Our Q1 masterclass explored what it means for biopharma communicators to show up fully as strategic partners, focusing on how we understand the business, structure our work, and make our impact more visible. Andrea Johnston led the session, bringing a builder’s perspective shaped by 30+ years across corporate, agency, and entrepreneurship (including one of the OG firms in our industry, Pure Communications). Here are 10 takeaways that stood out:
And, if you missed the session (or want a second pass), the replay and Andrea’s slides are available here. I particularly found the discourse around project- vs. value-based pricing (#7 above) intriguing and on-point as our profession evolves. Together, these points paint a clearer picture of where the role is heading, and where expectations are already shifting within our industry. A big thank you to Andrea for sharing so-many well-earned insights! We already have the Q2 masterclass cooking – stay tuned! Lynnea |
Hi! A quick reminder that tomorrow we’ll hold our Q2 Patient Advocacy & Engagement Roundtable event. This conversation will look at how biopharma communications are actually experienced by patient organizations... where messaging resonates, where it falls short, and what helps build stronger, more trusted relationships over time. Our speakers will share perspectives on what patient advocacy groups need from biopharma communicators, including how trust is built in practice, what makes...
Hi! Patient organizations are the closest link to the communities biopharma aims to serve. They see firsthand how messaging lands, including where it resonates, where it misses, and where it creates unintended friction. Our upcoming Patient Advocacy & Engagement Roundtable event brings together leaders across patient advocacy, healthcare communications, and patient-centered innovation to share how biopharma communications are experienced on the receiving end. What Patient Advocacy...
Hi! Our 2nd Annual Biopharma Comms Forum is just two months away. This year’s theme, Clarity at the Flashpoint, focuses on how biopharma communicators can operate when uncertainty is the norm rather than the exception. We have a full-day agenda planned that spans the biggest issues our community is facing. We'll discuss navigating AI disruption, how we can strengthen trust in science when skepticism is rising, and how to maintain influence when organizations are under pressure. Second Annual...